Abbarin, N., Papp, K., Vender, R., Langley, R. ., Ho, V., Park-Wyllie, L., Miller, M., You, Y., & Yang, Y.-W. (2023). PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. SKIN The Journal of Cutaneous Medicine, 7(6), s237. https://doi.org/10.25251/skin.7.supp.237